...
首页> 外文期刊>Cell death & disease. >SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells
【24h】

SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells

机译:SIRT1通过促进黑色素瘤细胞中E-钙黏着蛋白的自噬降解诱导上皮-间质转化

获取原文
           

摘要

Melanoma is highly metastatic, and understanding of its molecular mechanism is urgently needed for the development of therapeutic targets and prognostic assessment for metastatic melanoma. SIRT1 is a nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase, belonging to the mammalian sirtuin family. It has been reported that SIRT1 is associated with metastasis in various cancers. However, the molecular mechanism of SIRT1 in melanoma metastasis remains to be clarified. Here we report that SIRT1 induces the epithelial–mesenchymal transition (EMT) by accelerating E-cadherin degradation via autophagy and facilitates melanoma metastasis. Initially, we found that SIRT1 expression was frequently elevated in metastatic melanoma compared with primary melanoma. In addition, SIRT1 induced the EMT and promoted cell migration and invasion by decreasing E-cadherin expression. Further work demonstrated that SIRT1 accelerated the autophagic degradation of E-cadherin through deacetylation of Beclin 1. In addition, inhibition of autophagy recovered E-cadherin expression and suppressed cell migration and invasion by delaying the degradation of E-cadherin in SIRT1-overexpressing cells. Overall, our findings reveal a novel molecular mechanism for SIRT1 in melanoma metastasis, indicating that SIRT1 may serve as a viable therapeutic target for metastatic melanoma.
机译:黑色素瘤是高度转移性的,因此迫切需要了解其分子机制,以开发治疗性靶标和评估转移性黑色素瘤的预后。 SIRT1是烟酰胺腺嘌呤二核苷酸(NAD +)依赖性蛋白脱乙酰基酶,属于哺乳动物sirtuin家族。据报道,SIRT1与多种癌症的转移有关。然而,SIRT1在黑色素瘤转移中的分子机制仍有待阐明。在这里,我们报道SIRT1通过自噬加速E-钙粘蛋白降解并促进黑色素瘤转移,从而诱导上皮-间质转化(EMT)。最初,我们发现与原发性黑色素瘤相比,转移性黑色素瘤中SIRT1表达经常升高。此外,SIRT1诱导EMT,并通过降低E-钙黏着蛋白表达促进细胞迁移和侵袭。进一步的工作表明,SIRT1通过Beclin 1的脱乙酰作用促进E-钙粘蛋白的自噬降解。此外,自噬的抑制通过延迟SIRT1过表达细胞中E-钙粘蛋白的降解来恢复E-钙粘蛋白的表达并抑制细胞迁移和侵袭。总体而言,我们的发现揭示了SIRT1在黑色素瘤转移中的新分子机制,表明SIRT1可能成为转移性黑色素瘤的可行治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号